Swansea Bay City Deal and A Regional Collaboration for Health

Swansea University is proud to be part of the £1.3billion Swansea Bay City City Deal. Working through the A Regional Collaboration for Health (ARCH) partnership alongside Abertawe Bro Morgannwg (ABMU) and Hywel Dda University Health Boards, the Medical School is working to place the Swansea Bay City Region at the forefront of life science innovation and to be recognised as a destination of choice for global investment and enterprise in the field of life sciences and wellbeing.

The Life Science and Wellbeing strand of the City Deal agreement, which was signed in 2017, will see the development of Health Science Campuses at both Singleton and Morriston hospitals - which will build on the Medical School’s hugely successful Institute of Life Sciences (ILS 1&2). The second project within the Life Science and Wellbeing strand of the deal is the £200million Llanelli Life Science and Wellness Village planned for Delta Lakes.

Llanelli Wellness and Life Science Village

The £200million Llanelli Wellness and Life Science Village has now taken a major step forward, Carmarthenshire County Council has now signed a Collaboration Agreement with Swansea University and a private sector partner to develop the unique complex planned for Delta Lakes.

The Medical School is proud to be part of the Swansea University partnership which aims to bring a significant range of education provision to the site, which is expected to include training for doctors, nurses and other professionals for the life science and health sector. This includes collaboration with other education providers across the Swansea Bay City Region to focus on training opportunities for all levels of employment.

Sterling Health, the scheme’s private sector partner, which leads a prestigious consortium of global companies, will bring additional funding to the project. The Wellness & Life Science Village will feature state-of-the-art health, rehabilitation, well-being, sport and leisure amenities, plus independent research and medical facilities.
Overall project completion is scheduled for 2023.